Vimarsana
Biggest News Aggregation in the World

Page 7 - Arnab Chatterjee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arnab Chatterjee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arnab Chatterjee Today - Breaking & Trending Today

ZeroAvia, Edmonton Airport partner to develop hydrogen infrastructure - Vimarsana News

ZeroAvia, Edmonton Airport partner to develop hydrogen infrastructure

ZeroAvia has partnered with Edmonton International Airport to work on hydrogen infrastructure development for zero-emission flights.

ZeroAvia & Edmonton International Airport Tie Up to Bring Hydrogen-Electric Flights to Canada - Vimarsana News

ZeroAvia & Edmonton International Airport Tie Up to Bring Hydrogen-Electric Flights to Canada

/PRNewswire/ -- ZeroAvia, the leader in developing zero-emission solutions for commercial aviation, today announced a collaboration with Edmonton International...

ZeroAvia partners with Canadian airport to establish hydrogen infrastructure - Vimarsana News

ZeroAvia partners with Canadian airport to establish hydrogen infrastructure

ZeroAvia and Edmonton International Airport (EIA) in Canada have today (July 21) announced a collaboration to bring hydrogen-electric flight to the country.

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug - Vimarsana News

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

Scripps Research gets $67 million from NIH to lead new pandemic preparedness center - Vimarsana News

Scripps Research gets $67 million from NIH to lead new pandemic preparedness center

A major new antiviral drug development center led by Scripps Research in La Jolla to prime for the next pandemic is getting a $67 million award over three years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, with potential renewal for two additional years.